UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

Journal of clinical oncology, 2013-03, Vol.31 (7), p.853-859

2013

Link zum Volltext

Verfügbarkeit prüfen

Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Journal of clinical oncology, 2012-02, Vol.30 (5), p.482-487

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Study of Cetuximab in Combination With Cisplatin or Carboplatin and Fluorouracil in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2866-2872

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2873-2878

2006

Link zum Volltext

Verfügbarkeit prüfen

Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: Results of a GORTEC randomized trial

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.56-61

2011

Link zum Volltext

Verfügbarkeit prüfen

Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

Supportive care in cancer, 2008-09, Vol.16 (9), p.1017-1023

2008

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

The lancet oncology, 2021-05, Vol.22 (5), p.643-654

2021

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial

European journal of cancer (1990), 2020-07, Vol.133, p.86-93

2020

Link zum Volltext

Verfügbarkeit prüfen

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

The lancet oncology, 2015-01, Vol.16 (1), p.76-86

2015

Link zum Volltext

Verfügbarkeit prüfen

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

The lancet oncology, 2012-02, Vol.13 (2), p.145-153

2012

Link zum Volltext

Verfügbarkeit prüfen

Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial

European journal of cancer (1990), 2020-04, Vol.129, p.107-116

2020

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

The lancet oncology, 2021-05, Vol.22 (5), p.655-664

2021

Link zum Volltext

Verfügbarkeit prüfen

Intrapericardial instillation of bleomycin prevents recurrence of malignant pericardial effusions: Series of 46 cases and comprehensive literature review

Bulletin du cancer, 2020-07, Vol.107 (7-8), p.756-762

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT081: High-dose chemotherapy associated with bevacizumab for metastatic germ cell tumors: the TAXIF 3 trial

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT081-CT081

2016

Link zum Volltext

Verfügbarkeit prüfen

Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer

Health and quality of life outcomes, 2019-07, Vol.17 (1), p.129-129, Article 129

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer

Clinical genitourinary cancer, 2021-10, Vol.19 (5), p.e326-e333

2021

Link zum Volltext

Verfügbarkeit prüfen

Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials

Oral oncology, 2017-08, Vol.71, p.61-66

2017

Link zum Volltext

Verfügbarkeit prüfen

Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: Review of the literature and proposal for management changes

Oral oncology, 2013-06, Vol.49 (6), p.482-491

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Humans
(24)
Oncology
(24)
Male
(19)
Female
(18)
Middle Aged
(18)
Aged
(14)
Adult
(12)
Life Sciences
(11)
Tumors
(10)
Biological And Medical Sciences
(9)
Cancer
(9)
Chemotherapy
(9)
Medical Sciences
(9)
Treatment Outcome
(9)
Metastasis
(8)
Patients
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Cancer Therapies
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity

Phase I/II Study of Cetuximab in Combination With Cisplatin or Carboplatin and Fluorouracil in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary

Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: Results of a GORTEC randomized trial

Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial

The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

Intrapericardial instillation of bleomycin prevents recurrence of malignant pericardial effusions: Series of 46 cases and comprehensive literature review

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

Abstract CT081: High-dose chemotherapy associated with bevacizumab for metastatic germ cell tumors: the TAXIF 3 trial

Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer

Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer

Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials

Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: Review of the literature and proposal for management changes

Suchergebnisse filtern